<GlossaryTerm id="CDR0000393538"><TermName>interleukin-13 PE38QQR immunotoxin</TermName><TermPronunciation>(in-ter-LOO-kin … IH-myoo-noh-TOK-sin)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of cancer. It is made by combining interleukin-13 with a toxin from <ScientificName>Pseudomonas</ScientificName> bacteria. It is a type of recombinant chimeric protein.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000713395" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;interleukin-13 PE38QQR immunotoxin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000713394" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;interleucina-13 PE38QQR inmunotoxina&quot;" language="es" id="_4"/><SpanishTermName>interleucina-13 PE38QQR inmunotoxina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia que está en estudio para tratar el cáncer. Esta hecha de una combinación de interleucina-13 con una toxina de la bacteria <ScientificName>Pseudomonas</ScientificName>. Es un tipo de proteína quimérica recombinante.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-11-22</DateFirstPublished><DateLastModified>2007-04-06</DateLastModified></GlossaryTerm>
